IMMUNOCORE Trademark

Trademark Overview


On Monday, December 12, 2016, a trademark application was filed for IMMUNOCORE with the United States Patent and Trademark Office. The USPTO has given the IMMUNOCORE trademark a serial number of 87264976. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Saturday, November 30, 2024. This trademark is owned by Immunocore Limited. The IMMUNOCORE trademark is filed in the Computer & Software Services & Scientific Services and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the treatment of cancer, infectious diseases and autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer, infectious diseases and autoimmune diseases; immunotherapeutic drugs; reagents for medical use; Biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; diagnostic preparations for medical purposes; diagnostic reagents for medical use

[Pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological services, namely, research and design in the field of drug development for the treatment of cancer, infectious diseases and autoimmune diseases; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services]
immunocore

General Information


Serial Number87264976
Word MarkIMMUNOCORE
Filing DateMonday, December 12, 2016
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, November 30, 2024
Registration Number5410175
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer, infectious diseases and autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer, infectious diseases and autoimmune diseases; immunotherapeutic drugs; reagents for medical use; Biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; diagnostic preparations for medical purposes; diagnostic reagents for medical use
Goods and Services[Pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological services, namely, research and design in the field of drug development for the treatment of cancer, infectious diseases and autoimmune diseases; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services]

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateSaturday, November 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunocore Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Party NameImmunocore Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Trademark Events


Event DateEvent Description
Tuesday, March 14, 2017ASSIGNED TO EXAMINER
Wednesday, March 22, 2017NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 26, 2017ASSIGNED TO LIE
Thursday, December 15, 2016NEW APPLICATION ENTERED
Thursday, December 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 22, 2017NON-FINAL ACTION WRITTEN
Wednesday, October 25, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, October 25, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 25, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, November 8, 2017ELECTRONIC RECORD REVIEW COMPLETE
Saturday, September 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 25, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 3, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 20, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, November 20, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, November 30, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 30, 2024REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, November 30, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER